Blog
903 Articles
The Butterfly Effect and Living Every Day to My Fullest
Because Helene Avraham-Katz has the BRCA2 mutation, certain chemotherapies work better and she is eligible for specific clinical trials.
Precursors to Pancreatic Cancer: Are There Any Signs to Watch Out For?
Dr. Venkata Akshintala outlines some of the precursors to pancreatic cancer that people should look out for.
An Update on Vitamin C and Cancer
Vitamin C can have a positive impact on pancreatic cancer treatments. Read the latest research on vitamin C’s role in the fight against pancreatic cancer.
An Unexpected Diagnosis of PNET
Lisa Tayman was surprised to discover that the shoulder pain she had was from a pancreatic neuroendocrine tumor.
Testing a Combination for Metastatic Pancreatic Cancer
A clinical trial tests an investigational drug, immunotherapy, and radiation in combination against advanced pancreatic cancer.
Targeting the Undruggable KRAS Protein
Dr. Shubham Pant is focusing his research on effective treatments for the KRAS mutation, found in 90% of pancreatic cancers.
I’m Going to Live Every Day
Sharon Simone got a second opinion that led to a treatment protocol suited to her BRCA1 mutation. Now she is a long-term survivor.
A Life-Saving, Life-Changing Diagnosis
Randi C. Ervin’s primary care doctor suspected she had something more than prediabetes. Testing showed pancreatic neuroendocrine cancer.
Cancer Commons: Bringing a Nurse Navigator to Cancer Patients
Nurse navigator Deborah Christensen helps Cancer Commons patients through the maze of clinical trials and treatment options.
PancChat Featured in a Journal Article
PancChat co-host Dr. Niraj Gusani has coauthored an article about the advantages of social media for oncology surgeons.
Large Phase III Global Trial Targets Cancer Metabolism
Dr. Philip Philip focuses on disrupting cancer cell metabolism with devimistat, now in a phase III global clinical trial.
A Clinical Trial Saved My Life
Bob Minetti and his doctors believe that a clinical trial saved his life after a pancreatic cancer diagnosis.
Testing a PARP Inhibitor for Metastatic Pancreatic Cancer Patients with DNA Repair Mutations
Researchers are testing a PARP inhibitor that is effective for cancers in pancreatic cancer patients with DNA repair mutations.
Diversity Lacking in Pancreatic Cancer Trials
Drs. Kelly Herremans and Jose Trevino report on the lack of diversity in pancreatic cancer clinical trials, and possible root causes.
Catching Up with Featured Patients
Get patient updates on four of our most popular stories: Lynne Holcomb, Earl Groce, Roy Vinke, and Shannon Magee.